Lion's mane: the mushroom behind the focus claims

It looks like a white pom-pom someone left on a log, it has a name from a fantasy novel, and the tub says "focus". Lion's mane (Hericium erinaceus) is one of the most talked-about mushrooms on any smartshop shelf. So what is the focus reputation built on? It starts with compounds studied in cells and animals. The human studies are much smaller. And the preparation in your capsule matters, because each trial tested a specific version of the mushroom: which part of it was actually in the capsule?

What to know before you open the tub

• Lion's mane is a real, edible mushroom with a long culinary history in East Asia. The "grows new brain cells" story comes from cell and animal experiments, not from people.
• Human trials exist, but they are few and small. The most-cited one tested older adults with mild cognitive impairment; the two recent trials in healthy young adults found, at best, a result on one or two tests among many.
• "Lion's mane" on a label can mean fruiting body, mycelium grown on grain, or an extract of either. Studies tested specific versions, and the results don't automatically carry over to the others.
• Several of the key trials were supported or supplied by companies that sell lion's mane or products containing it. That doesn't make the results wrong, but it is worth knowing.
• Mycelium products sit in a different regulatory box from fruiting-body products in the EU (details below, read on 8 October 2026).

From log to supplement: what lion's mane is and why "focus" follows it around

Hericium erinaceus is a toothed fungus that grows on hardwood. Its cascade of soft white spines gives it the "lion's mane" and "pom-pom" nicknames; in Japan it is called yamabushitake. People eat the fresh fruiting body, and supplement makers use powders and extracts made from the fruiting body, from the mycelium (the thread-like vegetative body of the fungus), or from both.

The brain-health reputation comes from two families of compounds that researchers have isolated from it. The introduction to one recent trial puts it simply: the fruiting body is rich in hericenones, while the mycelium contains more erinacines (Surendran et al., 2025, Frontiers in Nutrition). In cell and animal experiments, both groups have been reported to promote nerve growth factor synthesis and to have neuroprotective effects (Docherty et al., 2023, Nutrients). That is a good reason to run human trials. It isn't the result of one, and "does something in a dish or a mouse" is a long way from "does something you'd notice at your desk".

What people have actually taken in trials

Here are the human studies, laid out so you can see what each one used and who took part.

• Study: Mori et al., 2009, Phytotherapy Research; Who: 30 Japanese adults aged 50–80 with mild cognitive impairment; What they took: Four 250 mg tablets (96% dried yamabushitake powder) three times a day for 16 weeks; Result in brief: Cognitive scores were higher than placebo at weeks 8, 12 and 16, then fell back four weeks after stopping; Who supported it: No funder stated in the summary
• Study: Li et al., 2020, Frontiers in Aging Neuroscience; Who: People with mild Alzheimer's disease, pilot trial; What they took: Three 350 mg capsules a day of erinacine A-enriched mycelium (5 mg/g erinacine A) for 49 weeks; Result in brief: Higher MMSE, CASI and daily-living scores than placebo; four people left over side effects (three on the mycelium, one on placebo): abdominal discomfort, nausea or a skin rash; Who supported it: Grape King Bio Inc. provided research materials and paid the salaries of five authors
• Study: Docherty et al., 2023, Nutrients; Who: 41 healthy adults aged 18–45; What they took: 1.8 g a day of a commercial lion's mane product, one dose and then 28 days; Result in brief: Faster on one Stroop task an hour after a single dose; a possible reduction in stress after 28 days that just missed the usual significance threshold (p = 0.051); Who supported it: The product was provided by Sempera Organics, which the paper says had no role in design, analysis or publication
• Study: Grozier et al., 2022, International Journal of Exercise Science; Who: 24 college-age adults; What they took: 10 g a day of lion's mane in muffins for four weeks (single-blind); Result in brief: No effect on the cognitive or metabolic measures tested; Who supported it: No funder stated in the summary
• Study: Surendran et al., 2025, Frontiers in Nutrition; Who: 18 healthy adults aged 18–35, crossover design; What they took: One 3 g dose of a 10:1 fruiting-body extract, tested 90 minutes later; Result in brief: No significant effect on the combined cognition or mood scores; one motor-skill test (the grooved pegboard) was better, while another test trended the other way; Who supported it: Two authors work for Three Spirit Drinks, a company that uses lion's mane plants in its products; it contributed to the publication fee

Reading the table, study by study

Mori 2009 is the foundation, and it is small. It is the study behind most "lion's mane helps memory" claims: thirty people, with mild cognitive impairment rather than healthy brains. The effect faded after people stopped, which is interesting, but one pilot trial can't tell you how big or lasting a benefit is. The summary also doesn't say which part of the mushroom the powder came from.

The erinacine A trial used a mycelium preparation you probably can't buy as an ordinary supplement. Li and colleagues tested mycelium enriched in one specific compound, in people with early Alzheimer's disease. That says little directly about a healthy 25-year-old taking a fruiting-body capsule, and the EU rules on mycelium (below) make that exact preparation an awkward fit for the shop shelf.

The two recent healthy-adult trials are modest. Docherty's team described their own results as tentative: one quicker task, a stress trend that didn't cross the line, and some null findings. Surendran's team, testing a single large dose of fruiting-body extract, found nothing on the overall cognition and mood measures and one better motor-skill result. Both are pilot-sized, and neither tested gaming, deep work or long study sessions, so neither supports a claim like "improves focus".

Longer use in young, healthy people is still thinly tested. Grozier's four-week muffin trial found nothing, and Docherty's 28-day phase, the closest thing to a longer test, was inconclusive. When a product page says "studies show", the useful follow-up is which of these it means.

A 2025 systematic review in Frontiers in Nutrition collected the clinical literature. Combining the scores from one randomised trial and one pilot trial gave a weighted mean MMSE increase of 1.17 points in the lion's mane groups (Menon et al., 2025). That is a small number from a small pool of trials.

Fruiting body, mycelium on grain, extract: what the label is telling you

This is where "lion's mane" stops being one thing. The trials above used at least four different materials, so a label needs to answer the question the study already asked.

• Label wording: Fruiting body (powder); What it usually means: Dried, ground mushroom; the part people eat; Question to ask: Is the part named on the pack? Mori's tablets used a dried powder; the trial summary doesn't say which part of the mushroom it came from.
• Label wording: Fruiting body extract (e.g. "10:1"); What it usually means: Water and/or ethanol extraction of the fruiting body, concentrated; Question to ask: Is the extraction ratio the only detail given? Surendran's extract is described by its ratio and process; a ratio alone doesn't say how much of any compound you get.
• Label wording: Mycelium (powder or extract); What it usually means: The fungus's vegetative body, often grown on grain; Question to ask: Is it separated from the grain? A product described as "mycelium on grain" or "myceliated oats" contains both fungus and substrate.
• Label wording: Mycelium plus fruiting body; What it usually means: A blend; Question to ask: Which proportion? A published safety study on one such powder describes it as mycelial biomass and fruiting body cultured on oats (Mahadevan et al., 2025; this was a rat study, not a human trial).
• Label wording: "Standardised to erinacine A" or "hericenones"; What it usually means: A target compound measured by the maker; Question to ask: Does the pack say how it was measured and how much per serving? Even then, a compound level describes what's in the product, not whether it works.

A few rules of thumb fall out of that:

• Trial results transfer best to a product that matches the studied one on part of the mushroom, extraction and dose. A "lion's mane" label alone doesn't tell you that.
• Beta-glucan, hericenone or erinacine numbers describe composition. None of the trials above were designed to link a compound level to an outcome.
• Third-party testing documents what is in a batch; it doesn't turn a food supplement into a treatment. Our guide to reading supplement labels walks through what these lines usually mean.

Safety, interactions and the EU's view of mycelium

Side effects. The trials report little, but they were small and short. The systematic review above lists stomach discomfort, headache and allergic reactions as possible effects that are often not reported (Menon et al., 2025). In the erinacine A pilot, four people left over side effects (abdominal discomfort, nausea or a skin rash): three on the mycelium and one on placebo, so it isn't a clean mycelium-only signal. If you react to other mushrooms, or you are pregnant, breastfeeding, giving it to a child, or take prescription medication, there isn't enough human data to say it's fine; our note on supplements and medicines explains why a pharmacist is a good first call. Memory problems that affect everyday life deserve a proper assessment rather than a mushroom: the NHS page on memory loss explains when to see a GP.

Mycelium and the EU. In a 2019 consultation on a lion's mane product, the Commission-hosted record of the Spanish food authority's assessment concluded that Hericium erinaceus dehydrated mycelium powder is a novel food in the EU, because no history of significant consumption of the mycelium before 15 May 1997 could be shown. The same document says the fruiting body does have a history of consumption before that date and that equivalence between the two parts could not be established (AESAN consultation record on Hericium erinaceus mycelium powder, 29 October 2019). That is a 2019 record for one product, read on 8 October 2026, not today's catalogue entry. Check the Commission's Novel Food Status Catalogue and, for a specific product, the Dutch food authority (NVWA), because rules and entries change.

Not psilocybin. Lion's mane is a culinary and supplement mushroom. It is unrelated to psilocybin mushrooms and truffles, which are a separate legal matter.

What the evidence adds up to

In people, the picture so far is this: a small pilot in older adults with mild cognitive impairment showed higher scores while they took the powder; an erinacine A mycelium pilot in early Alzheimer's did similarly; and the two recent trials in healthy young adults found mixed or null results, with a result on one or two tests at best. The preparations differed from study to study, several trials had company involvement, and none tested gaming or sustained work performance.

So lion's mane is an interesting mushroom with a promising lab story and a thin human one. If you enjoy it as food, that's easy. If you're buying it for a specific outcome, the research doesn't yet support expecting one, and a label that names the part of the mushroom, the extraction and the amount per serving gives you the best starting point for comparing products.

Related reading: how to read supplement labels, how supplements and medicines can interact, and our beginner's guide to supplements.

Where to read next

For the wider picture:

• Functional mushrooms and adaptogens: guide hub, for the six popular ingredients, each with its own guide, and a place to start.
• Gaming, focus and energy: guide hub, for how nootropics, caffeine pairings and plant extracts compare with gaming supplements and energy drinks.

Written by Smart Supplements with AI assistance from the sources linked in the text. It has not been reviewed by a clinician.

Last updated: 12 October 2026

This article is for informational purposes only and is not intended as medical advice. Always consult a healthcare professional before starting any new supplement, especially if you take prescription medication.